Javascript must be enabled to continue!
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
View through CrossRef
The selective pressures challenging the human population leave genetic signatures. This study was designed to detect positive and balancing selection on the proprotein convertase subtilisin/kexin type 6 (PCSK6) gene by four different approaches (FDIST, BayeScan, EHH, iHS). The outlier programs FDIST and BayeScan found 27 overlapping single nucleotide polymorphisms (SNPs) under selection, of which twelve are under strong positive directional selection and 15 under balancing selection. In the EHH analysis, all SNPs detected under positive selection show a slow decay of the derived extended haplotype. The integrated haplotype scores (iHS) for eight loci under positive selection were found to be larger than one. Based on these results, we provide a short overview of PCSK6-related mechanisms potentially associated with the detected positive or balancing selection patterns. Positive selection possibly reflects the key role of PCSK6 in tumorigenesis, in nociception, in rheumatoid arthritis and osteoarthritis, in the cardiovascular circulatory as well as in blood pressure regulation. Balancing selection acting on the PCSK6 locus might be explained by its involvement in vertebral left-right asymmetry and therefore in human handedness. Whereas until now the exact nature of the selective pressures acting on PCSK6 remained incompletely understood, the results of this study provide for the first time insights into the enzyme’s evolutionary significance owing to its functional manifoldness.
Title: Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
Description:
The selective pressures challenging the human population leave genetic signatures.
This study was designed to detect positive and balancing selection on the proprotein convertase subtilisin/kexin type 6 (PCSK6) gene by four different approaches (FDIST, BayeScan, EHH, iHS).
The outlier programs FDIST and BayeScan found 27 overlapping single nucleotide polymorphisms (SNPs) under selection, of which twelve are under strong positive directional selection and 15 under balancing selection.
In the EHH analysis, all SNPs detected under positive selection show a slow decay of the derived extended haplotype.
The integrated haplotype scores (iHS) for eight loci under positive selection were found to be larger than one.
Based on these results, we provide a short overview of PCSK6-related mechanisms potentially associated with the detected positive or balancing selection patterns.
Positive selection possibly reflects the key role of PCSK6 in tumorigenesis, in nociception, in rheumatoid arthritis and osteoarthritis, in the cardiovascular circulatory as well as in blood pressure regulation.
Balancing selection acting on the PCSK6 locus might be explained by its involvement in vertebral left-right asymmetry and therefore in human handedness.
Whereas until now the exact nature of the selective pressures acting on PCSK6 remained incompletely understood, the results of this study provide for the first time insights into the enzyme’s evolutionary significance owing to its functional manifoldness.
Related Results
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
Proprotein convertase subtilisin/Kexin type 9 (PCSK9) is a proteolytic enzyme that indirectly regulates serum LDL cholesterol by destroying LDL receptors. In clinical studies, the ...
Activation of Adiponectin Receptors Induces Proprotein Convertase Subtilisin Kexin Type 9 Expression by Activating PPARgamma Pathway
Activation of Adiponectin Receptors Induces Proprotein Convertase Subtilisin Kexin Type 9 Expression by Activating PPARgamma Pathway
Adiponectin is a hormone derived from adipose tissues. Reduced adiponectin levels have been determined to be associated with the occurrence of obesity‐linked diseases including ins...
Discovery of (2‐(4‐Substituted phenyl)quinolin‐4‐yl)(4‐isopropylpiperazin‐1‐yl)methanone Derivatives as Potent Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Discovery of (2‐(4‐Substituted phenyl)quinolin‐4‐yl)(4‐isopropylpiperazin‐1‐yl)methanone Derivatives as Potent Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
AbstractInhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an increasingly important role in the treatment of hyperlipidemia. In pursuit of potent small mole...
Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome
Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome
Objectives: This study aimed to investigate the potential roles of proprotein convertase subtilisin/ kexin type 9 (PCSK9) and apelin in the etiology of fibromyalgia syndrome (FS).
...
Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation
Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation
ObjectiveTo examine the effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) on gastric cancer (GC) progression and prognosis, and to explore the underlying mechanism.Me...
Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport
Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of low‐density lipoprotein receptor (LDLRs) molecules expressed on the cell surface. Gene inactivatio...
Successful use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report
Successful use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report
Background:
Managing hypertriglyceridemia-induced acute pancreatitis (HTG-AP)
can be challenging, particularly due to the need for rapid triglyceride reduction to below
500mg/dL (5...

